+

INNOVATION IN
DER BEHANDLUNG
IMMER ZUR HAND

BELIEBTE THEMEN

1

ESC 2021: HF & VHD Guidelines

ESC 2021: The Essentials of 2021 ESC Heart Failure and ESC/EACTS Guidelines for the management of valvular heart disease

2

bRIGHT study

bRIGHT study 1-year data card

3

ACC 2023: COAPT™ trial

ACC 2023: 5-year follow-up data from the COAPT™ trial

4

PCR LV 2021: Navitor™ Live-in-a-box

PCR London Valves 2021: Navitor™ with FlexNav™ Live-in-a box

5

ESOC 2022 PFO: FAQ

ESOC 2022 Frequently asked questions in patients with cryptogenic stroke and PFO

6

PCR LV 2021: Navitor™ 30-day outcomes

PCR London Valves 2021: Navitor™ with FlexNav™ TAVI system overview and 30 days outcomes

7

EXPAND Study: Data overview

Expand Study: Clinical Outcomes from the Global EXPAND Registry

8

Monitoring for AF prior to PFO closure

Monitoring for atrial fibrillation prior to patent foramen ovale closure

9

PFO Patient Brochure

PFO Patient Brochure

Connext
TV

NEUES AUS DER THERAPIE
VON STRUKTURELLEN
HERZERKRANKUNGEN

PORTFOLIO

MITRACLIP™ TEER

TRICLIP™ TEER

AMPLATZER™ AMULET™ LAAO

NAVITOR™ TAVI

TENDYNE™ TMVR

AMPLATZER™ TALISMAN™ PFO

AMPLATZER™ DUCT™ OKKLUDER

AKTUELL

Prognosis of TR after MitraClip for MR

EXPANDed studies analysis, presented by R. Estevez-Loureiro

TRILUMINATE Pivotal - 2-year update EuroPCR 25

TRILUMINATE Pivotal - 2-year update EuroPCR 2025, presented by G. Singh

Poster: Primary MR in the Very Elderly

Mitral TEER for Primary MR in the very elderly, presented by M. J. Price

bRIGHT 2-year real-world outcomes

bRIGHT 2-year real-world outcomes, presented by R. Bekeredjian

Navitor Valve in small aortic annuli

Now you’ve got Navitor for TAVI in small aortic annuli (SAA)

2-year outcomes from the TRILUMINATE Pivotal trial

2-year outcomes from the TRILUMINATE Pivotal trial

The Amulet IDE Trial

Five Year Results fom Amulet™ LAA Randomized Controlled Trial

Amplatzer™ Amulet™ LAA Occluder

Concomitant Catheter Ablation and LAA Occlusion with the Amplatzer™ Amulet™

Epic Mitral – 10-Year Clinical Outcomes

Ten-Year Follow-Up of Mitral Valve Replacement With the Epic Porcine Valve

ESOC presentation: PFO closure in patients > 60 Years

PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years

Data Summary PFO closure in patients > 60 Years

PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years

Amplatzer™ Septal Occluder (ASO) brochure

Amplatzer™ Septal Occluder (ASO) brochure- OPTIMAL OCCLUSION, PROVEN RESULTS

Amplatzer™ Septal Occluder (ASO) technical brochure

Amplatzer™ Septal Occluder (ASO) technical brochure

Talisman™ vs Gore^‡ Clinical Insights Brochure

Amplatzer™ Talisman™ PFO Occluder vs Gore^‡ Cardioform Septal Occluder Brochure

Talisman™ vs Occlutech^‡ Clinical Insights

Amplatzer™ Talisman™ PFO Occluder vs Occlutech^‡ Figulla Flex II PFO Occluder Brochure

Connext
Live

REGISTRIEREN SIE SICH
FÜR UNSER VIRTUAL VENUE.

Hören Sie Expertenmeinungen und entdecken Sie unsere Mediathek.

© Abbott 2024. All rights reserved. 9-GE-5-14559-02 07-2024

Der Inhalt dieser Website richtet sich an medizinisches Fachpersonal in der EMEA mit entsprechender Produktregistrierung durch die Gesundheitsbehörde, mit Ausnahme derjenigen, die in Frankreich praktizieren, da einige der Inhalte nicht mit dem französischen Werbegesetz N°2011-2012 vom 29. Dezember 2011, Artikel 34, übereinstimmen. Klicken Sie auf OK, um zu bestätigen, dass Sie Angehöriger eines Gesundheitsberufs sind, um fortzufahren.

OK ablehnen